Andrieu G, Amrouni H, Robin E, Carnaille B, Wattier J M, Pattou F, Vallet B, Lebuffe G
Department of Anaesthesiology and Intensive Care, Claude Huriez University Hospital, rue Michel Polonovski, 59037 Lille cedex, France.
Br J Anaesth. 2007 Oct;99(4):561-6. doi: 10.1093/bja/aem230. Epub 2007 Aug 6.
The use of regional anaesthesia in thyroid surgery remains controversial. This double-blind, randomized controlled study was conducted to evaluate the analgesic efficacy of bilateral superficial cervical plexus block (BSCPB) performed under general anaesthesia in patients undergoing total thyroidectomy.
Eighty-seven consecutive consenting patients were randomized to receive a BSCPB with saline (Group P, n = 29), ropivacaine 0.487% (Group R, n = 29), or ropivacaine 0.487% plus clonidine 5 microg ml(-1) (Group RC, n = 29). Sufentanil was given during the intraoperative period for a 20% increase in arterial mean pressure or heart rate in a patient with a bispectral index between 40 and 60. All patients received 4 g of acetaminophen during the first 24 h after operation. The pain score was checked every 4 h and nefopam was given for pain score >4 on a numeric pain scale.
During surgery, the median sufentanil requirements were significantly reduced in Group RC compared with Groups R and P (0.32 vs 0.47 and 0.62 microg kg(-1); P < 0.0001). After surgery, the number of patients requiring nefopam within 24 h of surgery was significantly lower in Groups R and RC than in Group P (16 and 19 vs 25; P = 0.03). At post-anaesthetic care unit admission, median (range) pain scores were significantly lower in Groups R [3 (0-10)] and RC [3 (0-8)] than in Group P [5 (0-8), P = 0.03]. No major complications of BSCPB occurred during study.
BSCPB with ropivacaine and clonidine improved intraoperative analgesia. BSCPB with ropivacaine or ropivaciane and clonidine was effective in reducing analgesic requirements after thyroid surgery.
甲状腺手术中区域麻醉的应用仍存在争议。本双盲随机对照研究旨在评估全身麻醉下双侧颈浅丛阻滞(BSCPB)对接受全甲状腺切除术患者的镇痛效果。
87例连续同意参与研究的患者被随机分为三组,分别接受生理盐水双侧颈浅丛阻滞(P组,n = 29)、0.487%罗哌卡因双侧颈浅丛阻滞(R组,n = 29)或0.487%罗哌卡因加5μg/ml可乐定双侧颈浅丛阻滞(RC组,n = 29)。术中,对于脑电双频指数在40至60之间且动脉平均压或心率升高20%的患者给予舒芬太尼。所有患者术后24小时内均接受4克对乙酰氨基酚。每4小时检查一次疼痛评分,数字疼痛量表评分>4分时给予奈福泮。
手术期间,RC组舒芬太尼的中位需求量显著低于R组和P组(0.32 vs 0.47和0.62μg/kg;P < 0.0001)。术后,R组和RC组术后24小时内需要奈福泮的患者数量显著低于P组(16例和19例 vs 25例;P = 0.03)。在麻醉后护理单元入院时,R组[3(0 - 10)]和RC组[3(0 - 8)]的中位(范围)疼痛评分显著低于P组[5(0 - 8),P = 0.03]。研究期间未发生BSCPB的重大并发症。
罗哌卡因联合可乐定的双侧颈浅丛阻滞改善了术中镇痛效果。罗哌卡因或罗哌卡因联合可乐定的双侧颈浅丛阻滞可有效减少甲状腺手术后的镇痛需求。